Institutions for Innovation

"Preventives versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals," with Christopher M. Snyder, Review of Industrial Organization, 53(1) (August 2018): 235 - 273. 

Duflo, Esther, and Michael Kremer. 2015. Which Innovations Reach More Than 100,000 or One Million People? Evidence from the Development Innovation Ventures Portfolio

“Global Public Goods in Communicable Disease Control,” in Infectious Disease, Expert Paper 
One. Stockholm: International Task Force on Global Public Goods, 2006.

“Creating Incentives For Private Sector Involvement In Poverty Reduction: Purchase Commitments For Agricultural Innovation,” with Alix Peterson Zwane in Inge Kaul and Pedro Conceição, eds., The New Public Finance Responding To Global Challenges. New York: Oxford University Press, 2006. 

Kremer, Michael, and Rachel Glennerster. 2004. Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases. Princeton, New Jersey: Princeton University Press. 

"Stimulating R&D on Vaccines for AIDS, Tuberculosis, and Malaria: The Role of Tax Credits for Sales of Vaccines to Non-Profit Organizations," 2000.

Kremer, Michael R. 1998. “Patent buyouts: A mechanism for encouraging innovation.” Quarterly Journal of Economics 113(4): 1137-1167.